News

Published on 9 May 2022 on Simply Wall St. via Yahoo Finance

Investors in Enzo Biochem (NYSE:ENZ) have unfortunately lost 73% over the last five years


Article preview image

Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Spare a thought for those who held Enzo Biochem, Inc. (NYSE:ENZ) for five whole years - as the share price tanked 73%. Shareholders have had an even rougher run lately, with the share price down 27% in the last 90 days.

It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that.

See our latest analysis for Enzo Biochem

NYSE.ENZ price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Enzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years...

Investing in stocks inevitably means buying into some companies that perform poorly. But the long...

Simply Wall St. via Yahoo Finance 14 Mar 2024

Jim Simons Trims Stake in Enzo Biochem Inc

Recent Stock Transaction Overview On December 29, 2023, Renaissance Technologies, led by Jim Simo...

GuruFocus.com via Yahoo Finance 14 Feb 2024

Here’s Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)

Laughing Water Capital, an investment management company, released its fourth-quarter 2023 invest...

Insider Monkey via Yahoo Finance 28 Jan 2024

Enzo Biochem (NYSE:ENZ) shareholders have endured a 63% loss from investing in the stock five years...

Generally speaking long term investing is the way to go. But unfortunately, some companies simply...

Simply Wall St. via Yahoo Finance 6 Oct 2023

Here’s Why Laughing Water Capital Made a Position in Enzo Biochem (ENZ)

Laughing Water Capital, an investment management company, released its second-quarter 2023 invest...

Insider Monkey via Yahoo Finance 19 Jul 2023

Enzo Biochem, Inc.'s (NYSE:ENZ) Popularity With Investors Is Under Threat From Overpricing

There wouldn't be many who think Enzo Biochem, Inc.'s (NYSE:ENZ) price-to-sales (or "P/S") ratio ...

Simply Wall St. via Yahoo Finance 8 Jun 2023

Enzo Biochem Insiders Added US$11m Of Stock To Their Holdings \

Over the last year, a good number of insiders have significantly increased their holdings in Enzo...

Simply Wall St. via Yahoo Finance 14 May 2023

Enzo Biochem (NYSE:ENZ) shareholders have endured a 58% loss from investing in the stock five years...

It is a pleasure to report that the Enzo Biochem, Inc. (NYSE:ENZ) is up 66% in the last quarter. ...

Simply Wall St. via Yahoo Finance 17 Apr 2023

Following a 26% decline over last year, recent gains may please Enzo Biochem, Inc. (NYSE:ENZ)...

Key Insights Institutions' substantial holdings in Enzo Biochem implies that they have significan...

Simply Wall St. via Yahoo Finance 18 Mar 2023

First Republic Bank's stock plunge continues despite $30 billion bank boost, FedEx's stock jumps...

These were some of the biggest movers and shakers in Friday trading:

Market Watch 17 Mar 2023